{"id":"NCT00492726","sponsor":"Bayer","briefTitle":"Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem","officialTitle":"A Prospective, Randomized, Double-dummy, Double-blind, Multicenter Trial Comparing the Safety and Efficacy of Intravenous Moxifloxacin 400 mg IV QD 24 Hours to That of Ertapenem 1.0 g IV QD 24 Hours for 5 to 14 Days for the Treatment of Subjects With Complicated Intra-abdominal Infections (PROMISE Study)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2009-02","completion":"2009-02","firstPosted":"2007-06-27","resultsPosted":"2010-03-03","lastUpdate":"2014-11-07"},"enrollment":804,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Infection"],"interventions":[{"type":"DRUG","name":"Moxifloxacin (Avelox, BAY12-8039)","otherNames":[]},{"type":"DRUG","name":"Ertapenem intravenous","otherNames":[]}],"arms":[{"label":"Moxifloxacin (Avelox, BAY12-8039)","type":"EXPERIMENTAL"},{"label":"Ertapenem","type":"ACTIVE_COMPARATOR"}],"summary":"A study to compare the safety and efficacy of moxifloxacin to ertapenem in patients with intra-abdominal infections.","primaryOutcome":{"measure":"Number of Subjects Achieving Clinical Cure at Test of Cure (TOC) Visit in the Per Protocol Population","timeFrame":"21 to 28 days after completion of study drug therapy","effectByArm":[{"arm":"Moxifloxacin (Avelox, BAY12-8039)","deltaMin":315,"sd":null},{"arm":"Ertapenem","deltaMin":324,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":32},"locations":{"siteCount":52,"countries":["Argentina","Belgium","Bulgaria","Estonia","France","Germany","Greece","Israel","Latvia","Lithuania","Romania","Russia","South Africa","Spain"]},"refs":{"pmids":["23153963"],"seeAlso":["http://www.clinicaltrialsregister.eu"]},"adverseEventsSummary":{"seriousAny":{"events":60,"n":408},"commonTop":["Wound infection","Lipase increased","Nausea","Diarrhoea"]}}